Research graph
References from Residual Disease in Adult Psoriasis‐Treated Patients: Frequency, Clinical Aspects, and Management. A Survey Among Dermatologists. Local targets link to admitted publications; unresolved targets remain external evidence.
Definition of Treatment Goals for Moderate to Severe Psoriasis: A European Consensus
10.1007/s00403-010-1080-1 · 2011 · External reference
PASI90 Response: The New Standard in Therapeutic Efficacy for Psoriasis
10.1111/jdv.12817 · 2015 · External reference
Clear or Almost Clear Skin Improves the Quality of Life in Patients With Moderate‐to‐Severe Psoriasis: A Systematic Review and Meta‐Analysis
10.1111/jdv.14007 · 2017 · External reference
10.1002/14651858.cd011535
10.1002/14651858.cd011535 · External reference
French Guidelines on the Use of Systemic Treatments for Moderate‐to‐Severe Psoriasis in Adults
10.1111/jdv.15340 · 2019 · External reference
Unresolved reference
External reference
Localization of Treatment‐Resistant Areas in Patients With Psoriasis on Biologics
10.1111/bjd.17689 · 2019 · External reference
Expert Consensus on Real‐World Use and Consumption Patterns of a Fixed‐Dose Combination Foam for Psoriasis as a Reactive Management (RM) and Proactive Management (PAM) Regimen
10.1007/s12325-022-02417-6 · 2023 · External reference
Proactive Treatment in Childhood Psoriasis
10.1016/j.annder.2019.07.005 · 2020 · External reference
Joint AAD‐NPF Guidelines of Care for the Management and Treatment of Psoriasis With Topical Therapy and Alternative Medicine Modalities for Psoriasis Severity Measures
10.1016/j.jaad.2020.07.087 · 2021 · External reference
Network Meta‐Analysis Comparing the Efficacy of Biologic Treatments for Achieving Complete Resolution of Nail Psoriasis
10.1080/09546634.2021.1892024 · 2022 · External reference
Effectiveness of Biologic Therapies in Children With Palmoplantar Plaque Psoriasis: An Analysis of Real‐Life Data From the BiPe Cohorts
10.1111/pde.15393 · 2023 · External reference
Psoriasis With Leg Involvement as the New Difficult‐to‐Treat Area: A Cohort Study of Patients Treated With Risankizumab
10.5826/dpc.1403a171 · 2024 · External reference
Residual Disease Is the Main, But Not the Only Factor Impacting Satisfaction in Psoriatic Patients Undergoing Biological Therapies
10.1111/ijd.17509 · 2025 · External reference
Improvements in Epidermal Function Prevent Relapse of Psoriasis: A Self‐Controlled Study
10.1111/ced.13888 · 2019 · External reference
